Work

The PHQ-9 works well as a screening but not diagnostic instrument for depressive disorder

Year: 2010
Type: article
Study design: Observational Study
Abstract: The PHQ-9 works well as a screening but not diagnostic instrument for depressive disorder QUESTION Question: Is the Patient Health Questionnaire 9 (PHQ-9) an accurate tool to screen for, diagnose and measure the severity of depressive disorder in groups that are at high risk for depressive disorder?Patients: A total of 664 high-risk patients aged between 18 and 70 years selected from patients enrolled at 6 health centres with 23 GPs and falling into one of 3 high-risk groups for depressive disorder: patients with unexplained somatic complaints; frequent attenders, defi ned as patients with consultation rates in the highest 10% in the year prior to study allocation; patients with a new mental health problem up to 3 months prior to the selection date.All participants completed the PHQ screening questionnaire.Setting: Amsterdam; primary care patients from two academic medical centres, The Academic Medical Centre in Amsterdam and the Radbound University Nijmegen Medical centre; recruited from March 2006 through July 2007.Test: The Patient Health Questionnaire-9, which evaluates the presence of one of the nine DSM-IV criteria of a depressive episode in the past 2 weeks: depressed mood, anhedonia, having trouble sleeping, feeling tired, change in appetite or weight, feelings of guilt and worthlessness, having trouble concentrating, feeling slowed down or restless, and having suicidal thoughts.Four response categories: 0 (not at all), 1 (few days), 2 (more than half the days), 3 (almost every day).Diagnostic standard: For assessment of screening and diagnostic properties: clinical diagnosis by trained researchers using the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) interview and for assessment of severity: the 17-item Hamilton Depression Rating Scale (HDRS-17).Outcomes: Sensitivity and specifi city for screening and diagnosing depressive disorders. METHODS Design: Diagnostic cohort study. MAIN RESULTSAn initial 2,659 patients met at least one criteria for high risk, but after exclusions by physicians, failure to return the questionnaire, lack of informed consent and failure to contact, 479 patients were available.PHQ-9 and SCID-I were analyzed in 440 patients, 17% of the original eligible group; another 82 of 664 (12.3%) of patients were diagnosed with depression using SCID-I.PHQ-9 performed well as a screening instrument: sensitivity: 0.93, 95 % CI 0.84 to 0.97; specifi city: 0.85, 95% CI: 0.82 to 0.97; and as a diagnostic tool, although there was a higher false-negative rate (lower sensitivity) and other measures, for example, sensitivity and specifi city (sensitivity: 0.68, 95 % CI 0.57 to 0.78; specifi city: 0.95, 95% CI 0.93 to 0.97).As a tool for assessing severity, correlation between scores on the PHQ-9 and HDRS-17 was low, r=0.52 (p<0.01). CONCLUSIONSThe PHQ-9 performs well as a screening instrument; however, in diagnosing depressive disorder, a formal diagnostic process following PHQ-9 remains imperative.The PHQ-9 does not seem adequate for measuring severity, compared to the HDSR-17.
Institution: Cal Poly Humboldt
Language: English
Field: Psychology
Open Access status: bronze
OpenAlex ID: W2019129401
FWCI: 0.499
Cites: 3
Cited by: 18
Related to: 10